Journal club 2013-09-13

9554.full

Transient Receptor Potential Canonical 3 (TRPC3) Is Required for IgG Immune Complex-Induced Excitation of the Rat Dorsal Root Ganglion Neurons

Chronic pain may accompany immune-related disorders with an elevated level of serum IgG immune complex (IgG-IC), but the underlying                        mechanisms are obscure. We previously demonstrated that IgG-IC directly excited a subpopulation of dorsal root ganglion (DRG)                        neurons through the neuronal Fc-gamma receptor I (FcγRI). This might be a mechanism linking IgG-IC to pain and hyperalgesia.                        The purpose of this study was to investigate the signaling pathways and transduction channels activated downstream of IgG-IC                        and FcγRI. In whole-cell recordings, IgG-IC induced a nonselective cation current (IIC) in the rat DRG neurons, carried by Ca2+ and Na+. The IIC was potentiated or attenuated by, respectively, lowering or increasing the intracellular Ca2+ buffering capacity, suggesting that this current was regulated by intracellular calcium. Single-cell RT-PCR revealed that                        transient receptor potential canonical 3 (TRPC3) mRNA was always coexpressed with FcγRI mRNA in the same DRG neuron. Moreover,                        ruthenium red (a general TRP channel blocker), BTP2 (a general TRPC channel inhibitor), and pyrazole-3 (a selective TRPC3                        blocker) each potently inhibited the IIC. Specific knockdown of TRPC3 using small interfering RNA attenuated the IgG-IC-induced Ca2+ response and the IIC. Additionally, the IIC was blocked by the tyrosine kinase Syk inhibitor OXSI-2, the phospholipase C (PLC) inhibitor neomycin, and either the inositol                        triphosphate (IP3) receptor antagonist 2-aminoethyldiphenylborinate or heparin. These results indicated that the activation of neuronal FcγRI                        triggers TRPC channels through the Syk–PLC–IP3 pathway and that TRPC3 is a key molecular target for the excitatory effect of IgG-IC on DRG neurons.

  • Received December 20, 2011.
  • Revision received May 20, 2012.
  • Accepted May 23, 2012.

Journal club 2013-09-13 Read More »

Journal club 2013-09-06

Essential Role for TRPC5 in Amygdala Function
and Fear-Related Behavior

1-s2.0-S0092867409003766-main PIIS0092867409003766.mmc1

Antonio Riccio,1,2 Yan Li,3 Jisook Moon,3,5 Kwang-Soo Kim,3 Kiersten S. Smith,3 Uwe Rudolph,3 Svetlana Gapon,1 Gui Lan Yao,2 Evgeny Tsvetkov,3 Scott J. Rodig,4 Ashlee Van’t Veer,3 Edward G. Meloni,3 William A. Carlezon Jr.,3 Vadim Y. Bolshakov,3,* and David E. Clapham1,2,*
1Department of Cardiology, Howard Hughes Medical Institute, Manton Center for Orphan Disease, Children’s Hospital Boston, Boston, MA 02115, USA

2Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA
3Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA
4Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115, USA
5Present address: College of Medicine, Pochon CHA University, 606-5 Yeoksam-dong, Gangnam-gu, Seoul 135-081, Republic of Korea *Correspondence: vadimb@mclean.harvard.edu (V.Y.B.), dclapham@enders.tch.harvard.edu (D.E.C.)
DOI 10.1016/j.cell.2009.03.039

SUMMARY

The transient receptor potential channel 5 (TRPC5) is predominantly expressed in the brain where it can form heterotetrameric complexes with TRPC1 and TRPC4 channel subunits. These excitatory, nonse- lective cationic channels are regulated by G protein, phospholipase C-coupled receptors. Here, we show that TRPC5

Journal club 2013-09-06 Read More »

Scroll to Top